0006 Illness usually occurs 7–10 days after consumption
of infected water or food, and the initial symptoms
tend to be both vague and variable. Headaches tend
to be common, as does a general feeling of lethargy,
along with abdominal pain/discomfort, and constipa-
tion is more usual than diarrhea. The fever increases
progressively during the first week, and then de-
creases, although a biphasic response may be seen.
Rose spots representing cutaneous vasculitis may be
seen on the abdomen and enlargement of the spleen
may be felt on abdominal palpation. The initial symp-
toms resemble those of acute gastroenteritis and Sal-
monella may be isolated from the feces. Then for a
week or more the organism may not be isolated from
the feces, although blood cultures are positive. This is
then followed by further fecal shedding. In about
25% of patients Salmonella may be isolated from
the urine. Fatalities usually arise from perforation
of the intestine after the bacteria have been localized
in the Peyer’s patches, and/or pneumonia, but other-
wise the disease runs a slow course over 5–6 weeks
and then leaves the patient in a longer period of
gradual convalescence.
0007 The pathogenesis of the disease is of interest. From
the small intestine the organisms pass via the lympha-
tics to the mesenteric lymph nodes, where, after a
period of multiplication, they invade the blood
stream via the thoracic duct and the liver, gall bladder,
spleen, kidney, and bone marrow become infected
during this bacteremic phase in the first 7–10 days of
the disease. From the gall bladder a further invasion
of the intestine occurs and lymphoid tissue, particu-
larly Peyer’s patches, are involved in an acute inflam-
matory reaction, followed by necrosis, sloughing, and
the formation of the characteristic typhoid ulcers.
Hemorrhage of varying degree may occur and, less
frequently, perforation through a necrotic Peyer’s
patch may complicate the illness and result in death.
S. typhi is present in large numbers in the inflamed
tissues in the ulcers and it may localize in the kidneys
and be found in other lesions that occur as a com-
plication or sequela of typhoid fever, e.g., acute sup-
purative periosteitis, renal and hepatic abscesses,
bronchopneumonia, and ulcerative endocarditis.
0008 In 2–5% of convalescents the organism persists in
the body, sometimes for an indefinite period, and in
such chronic carriers the organism is most commonly
found in the gall bladder or, more rarely, in the urin-
ary tract.
Diagnosis
0009 Typhoid fever should be suspected in any patient who
has visited an endemic area; the diagnosis is con-
firmed by recovering the organism from the feces,
urine, blood, or other tissues. Blood cultures are
positive in about 80% of patients and in the early
stages of illness, i.e., 7–10 days, it is the most reliable
diagnostic test. Bone marrow cultures and skin biop-
sies of rose spots are, however, more likely to be
positive for S. typhi than blood cultures. S. typhi
and paratyphi can be isolated from the feces through-
out the illness but are most frequently found during
the second and third weeks. Repeated examination of
the feces may be required before isolation is success-
ful. The tube agglutination test (Widal reaction) for
detecting antibodies to the somatic, flagellar H and
the envelope Vi antigen has been used for the sero-
logical diagnosis and positive titers occur about day
7–10 after infection. Occasionally positive titers de-
velop earlier, but they may be delayed and a negative
result at an early stage of the illness therefore may be
inconclusive (cross-reactions with other bacteria and
previous typhoid may give false-positive results).
Other serological tests, such as enzyme-linked immu-
nosorbent assays (ELISAs) have also been developed
to detect different antigens of the bacillus. Vaccin-
ation may give rise to false-positive serological reac-
tions and, if the patient has a history of vaccination, it
is advisable to take a second sample a week or so later
to determine whether there is a rising titer.
Chemotherapy
0010The treatment of enteric fevers necessitates the use
of antibacterial drugs. Chloramphenicol, ampicillin/
amoxicillin, trimethoprim/sulfamethoxazole are the
drugs of choice against sensitive Salmonella. Multiple
drug-resistant (MDR) isolates of S. typhi, resistant to
the first three antimicrobials (chloramphenicol, ampi-
cillin, and co-trimoxazole) have emerged in South-
east Asia and in 1998 in Kenya. Therapeutic options
include fluoroquinolones or azithromycin. Thus,
because MDRs of S. typhi have been reported, all
isolates should be tested for their antimicrobial sus-
ceptibility. Proper management of the fluid and elec-
trolyte balance is important in all patients, especially
the young and the old.
Immunoprophylaxis
0011Vaccines have been available for the prevention of
enteric fevers for many years. The classic inactivated
vaccine TAB protects against both typhoid and para-
typhoid A and B and extensive field trials in endemic
areas have shown a good degree of protection, al-
though a high percentage of vaccinates develop local
and systemic reactions.
0012In recent years, two new typhoid vaccines have
become available. A vaccine prepared from the Vi
capsular polysaccharide antigen has given good results
in field trials. One dose protects for 3 years and it has
a low incidence of side-effects. It is not licenced for
SALMONELLA
/Salmonellosis 5085